Hydromorphone HCL PF — Class III drug recall D-0023-2026
Ongoing recall by STAQ Pharma, Inc., reported 2025-10-22, distributed nationwide. Labeling: Incorrect or Missing Lot and/or Exp Date
| Recall number | D-0023-2026 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | STAQ Pharma, Inc., Denver, CO, United States |
| Recall initiated | 2025-10-09 |
| Classified | 2025-10-15 |
| Reported by FDA | 2025-10-22 |
| Distributed | Nationwide (US) |
| Reason classes | labeling |
| NDC | 73177-0104-05 |
| Lot numbers | 25104595A |
| Expiration dates | 2025-12-27 |
Product
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0023-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.